These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 18423604

  • 21. Drugs for men and women - how important is gender as a risk factor for TdP?
    Coker SJ.
    Pharmacol Ther; 2008 Aug; 119(2):186-94. PubMed ID: 18472167
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Supplemental studies for cardiovascular risk assessment in safety pharmacology: a critical overview.
    Picard S, Goineau S, Guillaume P, Henry J, Hanouz JL, Rouet R.
    Cardiovasc Toxicol; 2011 Dec; 11(4):285-307. PubMed ID: 21805209
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Drug-induced QT dispersion: does it predict the risk of torsade de pointes?
    Shah RR.
    J Electrocardiol; 2005 Jan; 38(1):10-8. PubMed ID: 15660342
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Assessing the proarrhythmic potential of drugs: current status of models and surrogate parameters of torsades de pointes arrhythmias.
    Thomsen MB, Matz J, Volders PG, Vos MA.
    Pharmacol Ther; 2006 Oct; 112(1):150-70. PubMed ID: 16714061
    [Abstract] [Full Text] [Related]

  • 28. Magnitude of QT prolongation associated with a higher risk of Torsades de Pointes.
    Lin YL, Kung MF.
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):235-9. PubMed ID: 19145580
    [Abstract] [Full Text] [Related]

  • 29. In vivo mechanisms precipitating torsades de pointes in a canine model of drug-induced long-QT1 syndrome.
    Gallacher DJ, Van de Water A, van der Linde H, Hermans AN, Lu HR, Towart R, Volders PG.
    Cardiovasc Res; 2007 Nov 01; 76(2):247-56. PubMed ID: 17669388
    [Abstract] [Full Text] [Related]

  • 30. Prediction of the risk of Torsade de Pointes using the model of isolated canine Purkinje fibres.
    Champeroux P, Viaud K, El Amrani AI, Fowler JS, Martel E, Le Guennec JY, Richard S.
    Br J Pharmacol; 2005 Feb 01; 144(3):376-85. PubMed ID: 15655517
    [Abstract] [Full Text] [Related]

  • 31. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?
    Nuttall GA, Eckerman KM, Jacob KA, Pawlaski EM, Wigersma SK, Marienau ME, Oliver WC, Narr BJ, Ackerman MJ.
    Anesthesiology; 2007 Oct 01; 107(4):531-6. PubMed ID: 17893447
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Beyond the safety assessment of drug-mediated changes in the QT interval... what's next?
    Pugsley MK, Authier S, Towart R, Gallacher DJ, Curtis MJ.
    J Pharmacol Toxicol Methods; 2009 Oct 01; 60(1):24-7. PubMed ID: 19616107
    [Abstract] [Full Text] [Related]

  • 34. Use of arterially perfused rabbit ventricular wedge in predicting arrhythmogenic potentials of drugs.
    Chen X, Cordes JS, Bradley JA, Sun Z, Zhou J.
    J Pharmacol Toxicol Methods; 2006 Oct 01; 54(3):261-72. PubMed ID: 16564186
    [Abstract] [Full Text] [Related]

  • 35. Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits.
    Wang WQ, Robertson C, Dhalla AK, Belardinelli L.
    J Pharmacol Exp Ther; 2008 Jun 01; 325(3):875-81. PubMed ID: 18322148
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Proarrhythmic potential of antimicrobial agents.
    Simkó J, Csilek A, Karászi J, Lorincz I.
    Infection; 2008 Jun 01; 36(3):194-206. PubMed ID: 18454341
    [Abstract] [Full Text] [Related]

  • 39. Clinical study of amiodarone-associated torsade de pointes in Chinese people.
    Geng DF, Jin DM, Wang JF, Luo YJ, Wu W.
    Pacing Clin Electrophysiol; 2006 Jul 01; 29(7):712-8. PubMed ID: 16884506
    [Abstract] [Full Text] [Related]

  • 40. Moxifloxacin-induced torsades de pointes.
    Sherazi S, DiSalle M, Daubert JP, Shah AH.
    Cardiol J; 2008 Jul 01; 15(1):71-3. PubMed ID: 18651388
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.